QuVa Pharma, Inc.

5 FDA enforcement actions

5 Total Recalls

0 Class I

4 Class II

1 Class III

Firm Details

Product Types: drug
States: TX, NJ

All Recalls

Class II: Risk 10/10/2025 drug

Presence of Particulate Matter
Class II: Risk 03/06/2025 drug

Lack of Assurance of Sterility
Class II: Risk 03/06/2025 drug

Lack of Assurance of Sterility
Class II: Risk 03/06/2025 drug

Lack of Assurance of Sterility
Class III: Low Risk 09/20/2022 drug

Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.